BioSpace News Archive

Gaumard Scientific Co., a health care simulation company committed to industry leadership through innovation, today announced the unveiling of the Gaumard Ultrasound system and the pediatric emergency scenario module for Pediatric HAL® S2225.

MilliporeSigma’s Andrew Bulpin will serve as a panelist during a virtual conversation with distinguished scientists and academic experts from both sides of the Atlantic on what lies ahead as the Covid-19 pandemic stretches into 2021 and vaccination campaigns are underway.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring.

Targeting the fast growing $60 billion asset performance management (APM) market, manufacturing AI analytics leader BISTel, says its expanded global sales footprint, together with enhanced cloud, Internet of things (IoT) and AI technologies will power a wave of new intelligent AI manufacturing applications in 2021

FORUS Therapeutics launches today, bringing a new pharmaceutical company onto the Canadian landscape. With a highly-experienced and proven team, an FDA-approved product already in its pipeline, and significant financial investment secured, the Toronto -based company looks to bring innovative cancer therapies to Canadian patients

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, after the market close.

Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/ . Date: February 10, 2021 Time: 4:30pm ET Listen via Internet: https://investor.pacificbiosciences.com/ Toll

Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) and Global Response Aid FZCO (GRA) today announced results from an Avigan study on moderate-severe hospitalized COVID-19 patients in Kuwait.

Confluent Medical Technologies Inc. (“Confluent”) today announced an expansion of its supply agreement with Allegheny Technologies (ATI) related to the manufacture and supply of ELI Nitinol, a specialized metal alloy used primarily to produce high-performance minimally invasive medical devices and components. Under the revised agreement, Confluent will provide funding to increase the furnace capacity at ATI Spec